Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million.
  • MyMD Pharmaceuticals (NASDAQ:MYMD) shares increased by 28.74% to $4.3. The company's market cap stands at $161.8 million.
  • Palisade Bio (NASDAQ:PALI) shares increased by 22.88% to $1.45. The company's market cap stands at $19.6 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock moved upwards by 20.68% to $1.75. The company's market cap stands at $57.3 million.
  • I-MAB (NASDAQ:IMAB) stock increased by 20.47% to $16.24. The company's market cap stands at $1.2 billion.
  • Zai Lab (NASDAQ:ZLAB) stock increased by 20.09% to $34.9. The market value of their outstanding shares is at $3.3 billion.

 

Losers

  • Incannex Healthcare (NASDAQ:IXHL) shares declined by 48.5% to $18.3 during Wednesday's pre-market session. The company's market cap stands at $884.6 million.
  • PolarityTE (NASDAQ:PTE) shares fell 13.97% to $0.3. The market value of their outstanding shares is at $24.8 million.
  • Surgalign Holdings (NASDAQ:SRGA) stock decreased by 12.13% to $0.29. The market value of their outstanding shares is at $56.2 million. As per the press release, Q4 earnings came out yesterday.
  • TRACON Pharmaceuticals (NASDAQ:TCON) shares declined by 11.12% to $2.4. The market value of their outstanding shares is at $46.6 million. As per the press release, Q4 earnings came out yesterday.
  • Vallon Pharmaceuticals (NASDAQ:VLON) stock declined by 7.94% to $7.05. The market value of their outstanding shares is at $48.0 million.
  • Better Therapeutics (NASDAQ:BTTX) shares fell 7.38% to $2.89. The company's market cap stands at $68.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.